Managers / Q3 2021 · view latest →
Thrive Capital Management, LLC
CIK 0001765681 · 295 LAFAYETTE STREET, 7TH FLOOR, NEW YORK, NY, 10012 · 646-680-0240
Summary
Thrive Capital Management, LLC reported $1.8B in U.S.-listed holdings across 9 positions for Q3 2021.
The portfolio is heavily concentrated: HOOD alone accounts for 46.6% of reported value.
Compared with Q2 2021, the fund opened 4 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $1.8B
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HOODRobinhood Markets Inc | NEW | +20.41M | 20.41M | +$859M | $859M |
| WRBYWarby Parker Inc | NEW | +613.8K | 613.8K | +$33M | $33M |
| BLNDBlend Labs Inc | NEW | +347.0K | 347.0K | +$5M | $5M |
| AMPLAmplitude Inc | NEW | +1.4K | 1.4K | +$74,000 | $74,000 |
| AFRMAffirm Holdings Inc | SOLD OUT | −3.94M | 0 | −$265M | $0 |
| Hims & Hers Health Inc | SOLD OUT | −85.6K | 0 | −$287,000 | $0 |
| HIMSHims & Hers Health Inc | TRIMMED | −12.10M | 3.20M | −$143M | $24M |
| OSCROscar Health Inc | ADDED | +4.76M | 37.61M | −$52M | $654M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HOODRobinhood Markets Inchistory → | COM CL A | 46.59% | $859M | 20.41M |
| 2 | OSCROscar Health Inchistory → | CL A | 35.48% | $654M | 37.61M |
| 3 | VMEO*Vimeo Inchistory → | COM | 9.32% | $172M | 5.85M |
| 4 | COMPCompass Inchistory → | CL A | 5.24% | $97M | 7.29M |
| 5 | WRBYWarby Parker Inchistory → | CL A COM | 1.77% | $33M | 613.8K |
| 6 | HIMSHims & Hers Health Inchistory → | COM | 1.31% | $24M | 3.20M |
| 7 | BLNDBlend Labs Inc | CL A | 0.25% | $5M | 347.0K |
| 8 | TWLOTwilio Inc | CL A | 0.04% | $686,000 | 1.7K |
| 9 | AMPLAmplitude Inc | COM CL A | 0.00% | $74,000 | 1.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $344M | 5 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $352M | 4 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $480M | 6 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $236M | 3 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $589M | 4 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $585M | 4 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.0B | 4 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $852M | 4 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $705M | 4 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $484M | 5 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $390M | 6 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $343M | 4 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $281M | 4 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $221M | 9 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $342M | 8 | Nov 18, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $482M | 8 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.1B | 11 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.1B | 9 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.8B | 9 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.5B | 7 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.4B | 6 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $927M | 5 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $462M | 4 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $58M | 2 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $81M | 2 | May 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $145M | 4 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $126M | 5 | Nov 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $154M | 4 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $199M | 2 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $599M | 2 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.